People: Endo Health Solutions Inc (ENDP.O)
17 Dec 2013
Mr. William F. Spengler is Independent Director of Endo Health Solutions Inc., (formerly Endo Pharmaceuticals Holdings Inc.), since 2008. From November 2010 until February 2012, Mr. Spengler was President of ChromaDex Corporation, a publicly traded company that in the development of phytochemical and botanical reference standards and that discovers, develops and markets novel, natural ingredients. From July 2008 until November 2010, Mr. Spengler served as Executive Vice President and Chief Financial Officer of Smith & Wesson Holding Corporation, a safety, security, protection and sport. Until March 2008, he was Executive Vice President and Chief Financial Officer at MGI Pharmaceuticals Inc., an oncology- and acute care- focused biopharmaceutical company, where he had worked since 2005. Prior to joining MGI Pharma, Mr. Spengler was Executive Vice President and Chief Financial Officer at Guilford Pharmaceuticals Inc., a bioscience company, from July 2004 to October 2005. From 2002 to 2004, Mr. Spengler served as President, Chief Operating Officer and Director of Osteoimplant Technology, Inc., an orthopedic products company. Mr. Spengler was previously a Vice President of Finance at Black & Decker, and prior to that spent 14 years in various finance, planning and business development positions at Bristol Myers Squibb.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|